Video Back Videos home Signature collection Essentials collection Artificial Intelligence ...

The study found that the new mRNA vaccine was successful in triggering an immune defense response that helped to reduce TB numbers in infected mice. In addition, the researchers discovered that ...

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Viruses ...

The study found that the new mRNA vaccine was successful in triggering an immune defence response that helped to reduce TB numbers in infected mice. In addition, the researchers discovered that ...

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

The Montana House on Wednesday voted down a bill that would have banned mRNA vaccines statewide, including the Covid-19 vaccine. After passing out of committee on a party line vote last week ...

BOISE, Idaho — Senate committee members heard arguments on a bill that would place a 10-year pause on administering mRNA vaccines in Idaho on Monday but did not take a vote. Sen. Brandon Shippy ...

Senate committee members heard arguments on a bill that would place a 10-year pause on administering mRNA vaccines in Idaho on Monday but did not take a vote. Sen. Brandon Shippy, R-New Plymouth ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

A few years ago, Moderna (NASDAQ: MRNA) stock soared on the back of the highly successful vaccine it developed in record time. At its peak in 2021, Moderna traded for over $450 per share.